| Management of pulmonary arterial hypertension in the neonatal unit. | |
| | |
MedLine Citation:
|
PMID: 20160532 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
This review article discusses the pathophysiology and management of pulmonary hypertension (PH) in the newborn unit. The discussion revolves around 2 aspects: persistent pulmonary hypertension in the newborn, which is seen in the first few weeks of life, and PH associated with chronic lung disease in the post neonatal period of infancy. Although the etiopathogenesis as well as prognosis for infantile PH differ from older children and adults, the basic principles of management are similar. Inhaled nitric oxide, intravenous prostacyclin and its analogs, and oral medications like sildenafil and endothelin receptor blockers play a very important role in PH management in the newborn unit, in addition to ventilation strategies and acid-based balance management. |
| | |
Authors:
|
Usha Krishnan |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiology in review Volume: 18 ISSN: 1538-4683 ISO Abbreviation: Cardiol Rev Publication Date: 2010 Mar-Apr |
Date Detail:
|
Created Date: 2010-02-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304686 Medline TA: Cardiol Rev Country: United States |
Other Details:
|
Languages: eng Pagination: 73-5 Citation Subset: IM |
Affiliation:
|
Department of Pediatric Cardiology, New York Medical College, Valhalla, NY 10595, USA. usha_krishnan@nymc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inflammation and pulmonary hypertension.
Next Document: New approaches to the treatment of pulmonary hypertension: from bench to bedside.